Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5.8Revenue $M0.1Net Margin (%)-801.7Z-Score-264.7
Enterprise Value $M5.2EPS $-0.0Operating Margin %-737.0F-Score5
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-877.9Higher ROA y-yY
Price/Book010-y EBITDA Growth Rate %2.5Quick Ratio0.8Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %0Current Ratio0.8Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-351.0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-236.3Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M144ROI % (ttm)-309.0Gross Margin Increase y-yY

Gurus Latest Trades with SGBI

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

SGBI is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!

SGBI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MCCANNA LAWRENCE EDirector 2013-08-13Sell3,125$24.78-99.84view
FLEING JOACHIMCFO, Secretary 2013-02-26Buy11,500$0.33-87.88view
SMITH ROBERT EDirector, 10% Owner 2012-06-08Buy22,500$7.96-99.5view
FLEING JOACHIMCFO, Secretary 2012-04-23Sell10,000$0.53-92.45view
FLEING JOACHIMCFO, Secretary 2012-04-02Sell3,100$0.75-94.67view
FLEING JOACHIMCFO, Secretary 2012-03-30Sell50,000$0.61-93.44view
FLEING JOACHIMCFO, Secretary 2012-03-30Sell50,000$0.61-93.44view
SMITH ROBERT EDirector, 10% Owner 2012-02-21Buy85,000$11.58-99.65view
FLEING JOACHIMCFO, Secretary 2011-12-08Buy150,000$0.2-80view
LEADER MARTIN RDirector 2011-09-16Buy668$8.38-99.52view

Press Releases about SGBI :

    Quarterly/Annual Reports about SGBI:

    News about SGBI:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    10-Q for Sangui Biotech International, Inc. Nov 16 2014
    SANGUI BIOTECH INTERNATIONAL INC Files SEC form 10-Q, Quarterly Report Nov 13 2014
    Sangui BioTech: Revenues Improved in the First Quarter of the 2015 Financial Year Nov 13 2014
    Sangui Biotech: Preclinical Trials Demonstrate: Sangui Hemoglobin Preparation Improves Oxygen Supply... Nov 11 2014
    Sangui BioTech International officially approved as trading on OTCQB Nov 06 2014
    Sangui BioTech: Laboratorios Silanes Start Marketing Granulox in Mexico Nov 03 2014
    Sangui BioTech Yields Revenues of over USD70,000 in Q1 2015 According to Preliminary Figures Oct 07 2014
    SANGUI BIOTECH INTERNATIONAL INC Files SEC form 10-K, Annual Report Sep 25 2014
    SanguiBioTech: Revenues Attain USD 133,000 in Financial Year 2014 Sep 25 2014
    Sangui BioTech: Start of preclinical trials Aug 06 2014
    SanguiBioTech yields revenues of around USD42,000 in Q4 2014 according to preliminary figures Jul 29 2014
    SANGUI BIOTECH INTERNATIONAL INC Files SEC form 10-Q, Quarterly Report May 15 2014
    SANGUI BIOTECH INTERNATIONAL INC Files SEC form 10-Q, Quarterly Report Feb 14 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial